Dermata Therapeutics, Inc. SEC filings DRMA
Dermata Therapeutics, Inc. has 371 filings in SEC EDGAR's recent list, going back to Apr 2, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 17, 2026 | Aug 16, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Auditor change
|
Feb 3, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 29, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Agreement ended
|
Nov 18, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Other events
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Other events
|
Aug 25, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 16, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 7, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Auditor change
|
Jun 5, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2025 | May 20, 2025 |
| 8-K |
Current report
Listing notice
|
May 16, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Mar 28, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 23, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 21, 2025 | Jan 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 17, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Aug 2, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Other events
|
Jun 5, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Listing notice
|
May 24, 2024 | May 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
May 17, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
May 15, 2024 | May 14, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 12, 2024 | Jan 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Nov 17, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 16, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Results of operations, Auditor change, Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Auditor change, Officer or director change, Shareholder vote results
|
Aug 3, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 20, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Feb 8, 2023 | Feb 8, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Dec 15, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 23, 2022 | Sep 21, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 11, 2022 | Jul 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 22, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Other events
|
May 17, 2022 | May 17, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 25, 2022 | Apr 20, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Other events
|
Mar 2, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Other events
|
Feb 4, 2022 | Feb 4, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 13, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 10, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 19, 2021 | Nov 19, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 1, 2021 | Sep 1, 2021 |
Showing 78 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DRMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1853816
- Former names
- Dermata Therapeutics, Inc. (until Nov 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.